Battle over authorized generics grows increasingly heated

April 1, 2005

Everyone knows market competition isn't pretty, but the battle between Big Pharma and generic manufacturers is often downright nasty. That's especially true as some generic companies fight Big Pharma—and one another—to stop a practice they find particularly abhorrent: authorized generics. The only thing everyone agrees about is that no one knows where the issue goes from here—to Congress or the Supreme Court.